CCO Oncology Podcast

189 Episodo

1. Targeting FGFR in Urothelial Cancer and Beyond

   Publicado: 23/3/2021
2. Expert Answers to HCP Questions on Pancreatic Cancer Treatment

   Publicado: 22/3/2021
3. Expert Answers to HCP Questions on CAR T-Cell Therapies in Lymphoma

   Publicado: 18/3/2021
4. Frequently Asked Questions on Emerging Antibody–Drug Conjugates in the Treatment of Advanced Non-Small-Cell Lung Cancer

   Publicado: 17/3/2021
5. Expert Answers to HCP Questions on CAR T-Cell Therapies in Myeloma and Management of Key Toxicities

   Publicado: 12/3/2021
6. Expert Insights on Highlights From ASH 2020 on Multiple Myeloma

   Publicado: 12/3/2021
7. Expert Insights on Key Data From ASH 2020 on Acute and Chronic Leukemias

   Publicado: 26/2/2021
8. Expert Insight on Key Data From WCLC 2020 in Early-Stage Lung Cancer

   Publicado: 24/2/2021
9. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Argentina

   Publicado: 22/2/2021
10. Expert Insights on Key Data From ASH 2020 on Nonmalignant Hematologic Disorders

    Publicado: 10/2/2021
11. Expert Insights on Key Data From ASH 2020 on Myelodysplastic Syndromes and Myeloproliferative Neoplasms

    Publicado: 5/2/2021
12. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Italy

    Publicado: 4/2/2021
13. Expert Answers to Questions on Contemporary Management of Hemophilia A

    Publicado: 4/2/2021
14. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the United States

    Publicado: 1/2/2021
15. An Expert Overview of Immunotherapy for Advanced HCC

    Publicado: 19/1/2021
16. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain

    Publicado: 8/1/2021
17. Expert Answers to Pathologist Questions on New Biomarkers for Precision Therapy in Lung Cance

    Publicado: 28/12/2020
18. Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy: FAQ

    Publicado: 24/12/2020
19. Practical Insights on Key Data From ESMO 2020 Informing Precision Medicine in NSCLC

    Publicado: 21/12/2020
20. Immunotherapy for Advanced HCC: Experts Answer Clinician Questions

    Publicado: 17/12/2020